Omeros Corp
OMER Nasdaq· Pharmaceutical Preparations
Last close · Oct 23, 2026
$16.57
KIRA · Stoqly’s AI analyst, in plain words
- Omeros Corp lost $3.4M in fiscal 2025.
- Free cash flow was −$116M in fiscal 2025, — of revenue.
- Omeros Corp returned $0.0M to shareholders in fiscal 2025.
- Omeros Corp has $82.7M more cash than debt.
Market cap
$1.5B
P/E
9.6x
Revenue
—
Net income
−$3.4M
Free cash flow
−$116M
Operating margin
—
Omeros Corp in 30 seconds · fiscal 2025
Does it make a profit?
−$3.4M
No. It lost money last year.
How is the share priced?
9.6x
One share costs 9.6 times its yearly profit per share.
What Omeros Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Legal name
- OMEROS CORP
- CIK
- 0001285819
Omeros Corp · OMER
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | $194M | $47.4M | −$118M | −$157M | −$3.4M |
| Diluted EPS | $3.12 | $0.76 | −$1.88 | −$2.70 | −$0.05 |
| Cash | |||||
| Cash from operations | −$110M | −$86.5M | $74.7M | −$149M | −$116M |
| Capital expenditure | $0.3M | $0.1M | $0.4M | $0.2M | $0.1M |
| Free cash flow | −$110M | −$86.6M | $74.3M | −$149M | −$116M |
| Share buybacks | $0.0M | $0.0M | $4.7M | $11.9M | $0.0M |
| Share count change | 9.0% | 0.6% | — | — | — |
| Debt and strength | |||||
| Cash and short-term investments | $157M | $195M | $172M | $90.1M | $172M |
| Debt incl. finance leases | $314M | $316M | $213M | $167M | $89.1M |
| Shareholders' equity | $23.8M | $85.7M | −$25.0M | −$183M | −$121M |
| Current ratio | 4.8x | 3.2x | 4.1x | 1.7x | 2.8x |
| Interest coverage | −8.8x | −7.2x | −5.3x | −6.8x | — |
| Returns and quality | |||||
| Return on capital | −76.2% | −62.6% | −796.2% | — | — |
| Return on equity | — | 86.6% | −388.2% | — | — |
| Return on tangible equity | 816.8% | 55.3% | — | — | — |
| Piotroski F-score | 4 | 2 | — | — | — |
| Altman Z'' | −5.0 | −1.8 | −6.6 | −13.9 | −9.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$3.0M
4 insiders
Of sales under plans
26%
$0.8M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Omeros Corp · OMER
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $16.57 a share, the company is worth $1.5B: 9.6 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001285819). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.